Development-stage platform with IP, prototype refinement, validation planning, and regulatory strategy.ΒΆ
Complex minimally invasive procedures can remain challenging when surgical workflows require precise coordination between clinicians, instruments, imaging, and procedural constraints.
Solution: Cobodoc is developing a clinician-supervised robotic assistance platform intended to support procedural consistency, workflow coordination, and future integration into complex clinical environments.
The company addresses a significant unmet need in procedures that require high procedural consistency, careful workflow coordination, and integration of surgical instruments, software, and clinical expertise.
Cobodoc controls a surgical-instrument IP portfolio, including patented cranial access and cranial fixation technologies, and is preparing additional intellectual-property filings for its next-generation robotic assistance platform.
The company is seeking investors, accelerators, angel groups, robotics/deep-tech VCs, strategic partners, and non-dilutive funding opportunities, including NIH SBIR/STTR pathways.
Technology position
Proprietary robotics, software, surgical-instrument know-how, and workflow-support architecture. Detailed technical materials are available under NDA.
IP position
Cobodoc controls a surgical-instrument IP portfolio, including patented cranial access and cranial fixation technologies, and is preparing additional filings for its next-generation robotic assistance platform.
Stage
Early proof-of-concept completed; prototype refinement, validation planning, regulatory strategy, and U.S. development roadmap underway.
Use of funds
IP filings, prototype refinement, preclinical validation planning, regulatory strategy, quality-system preparation, clinical and engineering partnerships, NIH SBIR/STTR preparation, and U.S. market development.
Target partners
Investors, accelerators, angel groups, robotics/deep-tech VCs, strategic medical-device partners, clinical collaborators, and NIH SBIR/STTR partners. Detailed technical materials and the development roadmap are available under NDA.
Qualified investors, accelerators, strategic partners, and non-dilutive funding organizations may request a confidential investor deck and technical roadmap under NDA.
Request confidential investor deck.
Our office
USA - HeadQuarter
1111B S Governors Ave, STE 6819
Dover, DE 19904, USA